Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_provenance.
- NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_assertion description "[The recommended treatment for patients infected with hepatitis C virus genotype 2 (HCV2) is pegylated interferon (peginterferon) and ribavirin for 24 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_provenance.
- NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_assertion evidence source_evidence_literature NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_provenance.
- NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_assertion SIO_000772 16956917 NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_provenance.
- NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_assertion wasDerivedFrom befree-20140225 NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_provenance.
- NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_assertion wasGeneratedBy ECO_0000203 NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP576088.RAxm8RzFbMraeYXzMLisgwTvfXKjrBSzSVuqHni0puCCQ130_provenance.